Neuroscience Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, IL 60064-6123, USA.
Trends Neurosci. 2010 Jan;33(1):48-57. doi: 10.1016/j.tins.2009.10.003. Epub 2009 Nov 14.
Chronic pain is characterized by enhanced sensory neurotransmission that underlies increased sensitivity to noxious stimuli and the perception of non-noxious stimuli as painful. Evidence from neurophysiological and pharmacological studies demonstrates that ATP produces pain by directly enhancing neuronal excitability via the activation of specific ligand-gated ion channels, the P2X3 and P2X2/3 receptors. In addition, ATP activates CNS glial cells (e.g. microglia) in response to persistent nociceptive stimulation. This latter effect involves several distinct receptor-mediated signaling pathways linked to the P2X4, P2X7 and P2Y(12) receptors. This review summarizes new data that places these purinergic signaling events in a mechanistic context that illustrates the ability of ATP to initiate and maintain states of heightened sensory neuron excitability associated with persistent pain.
慢性疼痛的特征是感觉神经递质传递增强,这是对有害刺激的敏感性增加和对无害刺激的感知为疼痛的基础。神经生理学和药理学研究的证据表明,ATP 通过激活特定的配体门控离子通道 P2X3 和 P2X2/3 受体,直接增强神经元兴奋性而产生疼痛。此外,ATP 还会激活中枢神经系统胶质细胞(如小胶质细胞)对持续的伤害性刺激作出反应。后一种效应涉及几种不同的受体介导的信号通路,这些通路与 P2X4、P2X7 和 P2Y(12)受体有关。这篇综述总结了新的数据,将这些嘌呤能信号事件置于一个机制背景下,说明了 ATP 启动和维持与持续性疼痛相关的感觉神经元兴奋性增强状态的能力。